Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2022 Earnings Call Transcript March 10, 2023
Operator: Greetings, and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. As a reminder, this conference is being recorded. It is now my pleasure to introduce to your host, Chris Calabrese. Thank you, Chris. You may begin.
Chris Calabrese: Thank you, and good morning. Welcome to the Fulcrum Therapeutics Fourth Quarter and Full Year 2022 Financial Results and...
